Sudden Cardiac Death

Definition

Sudden cardiac death (SCD) is an unexpected death due to a cardiovascular event occurring within 1 hour of symptom onset (if witnessed) or within 24 hours of last being seen alive (if unwitnessed).

Key Concepts

• SCD accounts for approximately 50% of all cardiovascular deaths. The 2017 AHA/ACC/HRS guideline estimates 230,000–350,000 SCD per year in the US (range <170,000 to >450,000 depending on epidemiological methodology); the 2017 AHA statistics estimated 356,500 out-of-hospital cardiac arrests annually. (sources/va-scd-aha-2017, rating: very high) (Previous estimate of 250,000–300,000 from sources/channelopathies-jaha-2025)

• Out-of-hospital cardiac arrest (OHCA) survival: ~10% overall (6% when arrest occurs at home; best outcomes from witnessed arrest + bystander CPR + AED + shockable initial rhythm). In-hospital cardiac arrest survival to discharge: ~24%. (sources/va-scd-aha-2017, rating: very high)

• At least 25% of SCD cases are the first symptomatic cardiac event (sources/va-scd-aha-2017); up to half of SCD cases represent the first clinical manifestation of underlying heart disease. (sources/channelopathies-jaha-2025)

• Age-dependent etiology: In younger individuals, primary electrical disorders, cardiomyopathies, myocarditis, and coronary anomalies predominate. From the fourth decade onward, coronary artery disease (especially acute coronary syndrome) accounts for ~50% of cases. In older populations, chronic structural diseases dominate. (sources/channelopathies-jaha-2025)

• Channelopathies account for >50% of SCD in individuals aged <50 years, making them a critical target for prevention in young patients. (sources/channelopathies-jaha-2025)

• Risk factors for SCD include hypertension, diabetes, dyslipidemia, obesity, and family history of SCD. (sources/channelopathies-jaha-2025)

• The primary arrhythmic mechanism in channelopathy-related SCD is ventricular fibrillation (VF), often initiated by torsades de pointes (LQTS), bidirectional VT (CPVT), or short-coupled PVCs (IVF/ERS). (sources/channelopathies-jaha-2025)

• SCD in HCM — detailed epidemiology: SCD incidence 0.5–1%/year; mainly affects patients <30 years old; cumulative childhood HCM SCD rate over 5 years is ~8–10%; HCM is the leading cause of SCD in young people in North America. SCD risk decreases with age and is rare in patients >60 years. SCD may be the first clinical manifestation of HCM. (sources/HCM-VA-FCVMed-2022)

• SCD in cardiomyopathies: In HCM, annual cardiovascular mortality is 1–2%; SCD rates in children are ~1.2–1.5% per year (still >50% higher than in adult HCM). SCD is very rare in HCM below age 6. (sources/esc-cmp-2023)

• Genotype-driven SCD risk in NDLVC/DCM: High-risk genotypes with substantially elevated arrhythmic SCD risk (regardless of LVEF): PLN, TMEM43, DES, DSP, LMNA, FLNC (truncating), RBM20. ICD is recommended even with LVEF >35% in these genotypes when additional risk factors are present. (sources/esc-cmp-2023)

• DCM annual VA event rate: The crude annual rate of sustained VA in non-ischaemic DCM is 4.5% (meta-analysis of 55 studies, 11,451 patients). This encompasses VT, VF, resuscitated SCD, and appropriate ICD discharges. (sources/VA-DCM-Sammani-2020)

• Multi-parameter VA predictors in DCM: LGE (HR 5.55), prior sustained VA (HR 4.15), hypertension (HR 1.95), LVEF on echo (HR 1.45), LV dilatation (HR 1.10), younger age (HR 0.82), plus genetic mutations PLN/LMNA/FLNC. LVEF-only risk stratification is insufficient for non-ischaemic DCM. (sources/VA-DCM-Sammani-2020) See concepts/VA-Risk-Stratification-DCM.

• HCM risk stratification: HCM Risk-SCD calculator (≥16 years) and HCM Risk-Kids (<16 years) provide validated 5-year SCD probability estimates. ICD is Class IIa when 5-year risk ≥6%. See concepts/HCM-Risk-SCD. (sources/esc-cmp-2023)

• SCD in ARVC: Beta-blockers and exercise restriction are the cornerstones of SCD prevention; catheter ablation reduces VT burden but does not prevent SCD. (sources/esc-cmp-2023)

• ESC 2022 global SCD epidemiology:

  • SCD incidence: ~1/100,000/year in children; ~50/100,000 in middle-aged; ≥200/100,000 in the 8th decade. (sources/VA-SCD-ESC-2022)
  • Males have higher SCD rates at every age even after CAD risk factor adjustment. (sources/VA-SCD-ESC-2022)
  • 10–20% of all European deaths are SCD; ~300,000 OHCA treated by EMS annually in Europe. (sources/VA-SCD-ESC-2022)
  • CAD accounts for 75–80% of SCD in Western populations; its absolute incidence is declining but proportion of cardiovascular deaths from SCD may be increasing. (sources/VA-SCD-ESC-2022)
  • In individuals <50 years, inherited electrical diseases and structural non-ischaemic diseases cause >50% of SCD — CAD only becomes dominant from the 4th decade. (sources/VA-SCD-ESC-2022)
  • SADS (Sudden Arrhythmic Death Syndrome): Unexplained SD >1 year old with negative pathological and toxicological assessment; synonymous with "autopsy-negative sudden unexplained death." (sources/VA-SCD-ESC-2022)
  • Systematic evaluation of relatives after SADS uncovers an inheritable cardiac disease in a significant proportion of families — structured screening flowchart provided in ESC 2022. (sources/VA-SCD-ESC-2022)
  • Bystander CPR + AED: Prompt bystander CPR and public AED access are Class I recommendations; mobile app alerting of BLS-trained volunteers is Class IIa (new 2022). (sources/VA-SCD-ESC-2022)

Circadian and Day-Night Patterns in SCA

• Historical morning SCA peak: For decades, studies identified a morning peak in SCA incidence in both ischemic and non-ischemic heart disease — attributed to morning surges in sympathetic signaling, catecholamines, heart rate, platelet aggregation, and afterload. (sources/circadian-scd-jmcc-2025, rating: high)

• Loss of morning peak in contemporary populations: Recent registries (Oregon SUDS, SCD-HeFT) no longer confirm a distinct morning SCA peak. Proposed explanations include widespread beta-blocker use blunting morning sympathetic surges, modern lifestyle changes (shift work, irregular sleep-wake cycles), and improved CVD risk factor management. (sources/circadian-scd-jmcc-2025, rating: high)

• Overall daytime SCA incidence persists: Higher SCA rates during daytime hours remain regardless of age, sex, and CAD status — reflecting the persistent daytime elevation of arrhythmogenic triggers even without a discrete morning peak. (sources/circadian-scd-jmcc-2025, rating: high)

• Trigger-substrate framework: SCA risk arises from the interaction between arrhythmogenic triggers (sympathetic signaling, catecholamines, elevated HR/afterload, platelet aggregation) and the protective properties of the myocardial substrate (conduction velocity, refractory periods, repolarization homogeneity, coupling efficiency). A compromised substrate enables triggers to initiate sustained lethal arrhythmias. (sources/circadian-scd-jmcc-2025, rating: high)

• Intrinsic cardiac clock and substrate protection: Isolated heart studies (at constant temperature, after autonomic washout) demonstrate time-of-day differences in APD, ERP, Ca²⁺ transient duration, and adrenergic responsiveness — with a peak in arrhythmia resistance at the start of the dark (active) cycle. Cardiomyocyte-specific Bmal1 knockout abolishes this time-of-day protection. (sources/circadian-scd-jmcc-2025, rating: high)

• Aging reduces circadian substrate protection: Aged mice (18–20 months) lose the time-of-day arrhythmia resistance peak seen in young mice, suggesting that aging diminishes circadian modulation of myocardial substrate protection. (sources/circadian-scd-jmcc-2025, rating: high)

• LQT2 and time-of-day arrhythmia risk: KCNH2 mutations shortening Kv11.1 protein t½ to <6 h amplify circadian APD swings — providing a mechanistic link between inherited channelopathy, circadian rhythm, and time-of-day arrhythmia clustering. See entities/Long-QT-Syndrome and concepts/Circadian-Rhythm-Cardiac-Electrophysiology. (sources/circadian-scd-jmcc-2025, rating: high)

• Obesity as the most common non-ischaemic SCA cause: Every 5-unit BMI increment confers 16% higher SCD risk; mechanisms include LVH, QT prolongation, premature ventricular complexes, autonomic imbalance, and epicardial fat infiltration. See entities/Obesity and concepts/Epicardial-Adipose-Tissue-Arrhythmogenesis. (sources/obesity-cv-aha-2021, rating: very high)

• AHA 2017 VA mechanisms: SCA/SCD from VA is mediated by three mechanisms: (1) enhanced automaticity (idiopathic VT, accelerated idioventricular rhythm in AMI); (2) triggered activity — early afterdepolarizations (EADs) → TdP in LQTS; delayed afterdepolarizations (DADs) → CPVT, digoxin toxicity, idiopathic outflow tract VA, HF-related VA; (3) reentry — the dominant mechanism for sustained VT in structural heart disease, circulating around scar (post-MI) or functional block. (sources/va-scd-aha-2017, rating: very high)

• AHA 2017 SCD age-stratified risk: Annual SCD risk ~1/100,000 in children/adolescents; steep increase from mid-20s to 35–40 years as ischemic HD emerges; ~1/1,000/year from age 35. SCD is uniformly more common in men at all ages. SCD incidence may decrease after age 75. (sources/va-scd-aha-2017, rating: very high)

• Primary prevention ICD for SCD prevention in ischemic HD provides high value (<$50,000/QALY) when arrhythmic death risk is high and competing nonarrhythmic mortality is low. Secondary prevention ICD provides intermediate value ($64,000–$100,000/QALY). (sources/va-scd-aha-2017, rating: very high)

Contradictions / Open Questions

• HCM SCD rate — all-cause cardiovascular mortality vs. SCD-specific rate: HCM-VA-FCVMed-2022 reports SCD incidence 0.5–1%/year and childhood HCM 5-year SCD rate ~8–10%. ESC CMP 2023 reports annual cardiovascular mortality of 1–2%, which includes non-SCD cardiovascular deaths. Using these figures interchangeably conflates overall cardiovascular mortality with arrhythmic SCD, which may overestimate SCD risk and influence ICD implantation decisions. (sources/HCM-VA-FCVMed-2022, sources/esc-cmp-2023)
• Channelopathies account for >50% of SCD <50 years — population vs. referral cohort bias: The statistic that channelopathies account for >50% of SCD in individuals aged <50 derives from specialized referral populations and autopsy-negative SCD cohorts at expert centres. In unselected community SCD registries, CAD remains the dominant etiology even in younger adults. The true channelopathy SCD burden in the general population may be lower, which affects public health prioritization of screening programs. (sources/channelopathies-jaha-2025, sources/VA-SCD-ESC-2022)

Connections

• Related to entities/HCM
• Related to concepts/Ion-Channel-Remodeling-in-HCM
• Related to concepts/Calcium-Homeostasis-in-HCM
• Related to concepts/HCM-Risk-SCD
• Related to concepts/Ion-Channel-Mutations
• Related to concepts/Torsades-de-Pointes
• Related to entities/Long-QT-Syndrome
• Related to entities/Brugada-Syndrome
• Related to entities/CPVT
• Related to entities/Idiopathic-Ventricular-Fibrillation
• Related to entities/Early-Repolarization-Syndrome
• Related to concepts/Electrical-Storm
• Related to entities/Andersen-Tawil-Syndrome
• Related to concepts/VA-Risk-Stratification-DCM
• Related to entities/ARVC
• Related to entities/DCM
• Related to entities/PLN
• Related to entities/LMNA
• Related to entities/FLNC
• Related to entities/HCM
• Related to concepts/Ion-Channel-Remodeling-in-HCM
• Related to concepts/Calcium-Homeostasis-in-HCM
• Related to concepts/HCM-Risk-SCD
• Related to concepts/Ion-Channel-Mutations
• Related to concepts/Torsades-de-Pointes
• Related to entities/Long-QT-Syndrome
• Related to entities/Brugada-Syndrome
• Related to entities/CPVT
• Related to entities/Idiopathic-Ventricular-Fibrillation
• Related to entities/Early-Repolarization-Syndrome
• Related to concepts/Electrical-Storm
• Related to entities/Andersen-Tawil-Syndrome
• Related to concepts/VA-Risk-Stratification-DCM
• Related to concepts/Circadian-Rhythm-Cardiac-Electrophysiology — circadian modulation of trigger-substrate SCA risk; loss of morning peak; aging effects
• Related to entities/Obesity — most common non-ischaemic SCA cause; epicardial fat mechanisms
• Related to concepts/Epicardial-Adipose-Tissue-Arrhythmogenesis — EAT → fibro-fatty infiltration → VT/SCD substrate
• Related to sources/circadian-scd-jmcc-2025

Sources

• sources/va-scd-aha-2017
• sources/HCM-VA-FCVMed-2022
• sources/VA-DCM-Sammani-2020
• sources/VA-SCD-ESC-2022
• sources/channelopathies-jaha-2025
• sources/circadian-scd-jmcc-2025
• sources/esc-cmp-2023
• sources/obesity-cv-aha-2021